Open AccessUse and Impact of the 21-Gene Recurrence Score in Relation to the Clinical Risk of Developing Metastases in Early Breast Cancer Patients in the Netherlands
Author(s) -
Kay Schreuder,
Anne Kuijer,
Sanne Bentum,
Thijs van Dalen,
Sabine Siesling
Publication year - 2018
Publication title -
public health genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 51
eISSN - 1662-8063
pISSN - 1662-4246
DOI - 10.1159/000495742
Subject(s) - medicine , breast cancer , guideline , cancer , oncology , chemotherapy , clinical trial , pathology
The nationwide use of the 21-gene recurrence score (21-RS) and implications regarding chemotherapy administration in relation to clinical risk in early breast cancer patients are investigated.